SCHEMBL24012151

SCHEMBL24012151

CC(C)c1cccc(C(C)C)c1N1C(=O)c2ccc3c4c(ccc(c24)C1=O)-c1ccccc1C3=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 5/20 0.58
▸ NR1H2 P55055 1/20 0.58
▸ NR1H3 Q13133 1/20 0.58
▸ ANPEP P15144 5/20 0.56
▸ PABPC1 P11940 2/20 0.45
▸ MAPT P10636 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ DNMT1 P26358 1/20 0.45
▸ CASP1 P29466 1/20 0.45
▸ CASP7 P55210 1/20 0.45
▸ FAAH O00519 1/20 0.37
▸ MGLL Q99685 1/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.36
▸ MAPK13 O15264 1/20 0.36
▸ EIF2AK2 P19525 1/20 0.36
▸ MAPK12 P53778 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30954668 0.89 ANPEP (0.67) DPP4NR1H2NR1H3ANPEPCYP3A4
SCHEMBL17531021 0.89 ANPEP (0.67) DPP4NR1H2NR1H3ANPEPCYP3A4
SCHEMBL2820118 0.84 DPP4 (0.78) DPP4NR1H2NR1H3ANPEPFAAH
SCHEMBL29366407 0.84 DPP4 (0.78) DPP4NR1H2NR1H3ANPEPFAAH
SCHEMBL13478139 0.83 ANPEP (0.60) DPP4NR1H2NR1H3ANPEPMAPT
SCHEMBL18071847 0.83 ANPEP (0.60) DPP4NR1H2NR1H3ANPEPMAPT
SCHEMBL29369271 0.83 ANPEP (0.60) DPP4NR1H2NR1H3ANPEPMAPT
SCHEMBL3438530 0.83 ANPEP (0.60) DPP4NR1H2NR1H3ANPEPMAPT
SCHEMBL29461625 0.83 ANPEP (0.60) DPP4NR1H2NR1H3ANPEPMAPT
SCHEMBL300362 0.81 DPP4 (0.61) DPP4NR1H2NR1H3ANPEPKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210351356-A1 IMIDE DERIVATIVE, LUMINESCENT COMPOSITION CONTAINING SAME, LUMINOUS THIN FILM, AND LUMINOUS PARTICLES Konica Minolta, Inc. (JP) 2021-11-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210351356-A1 IMIDE DERIVATIVE, LUMINESCENT COMPOSITION CONTAINING SAME, LUMINOUS THIN FILM, AND LUMINOUS PARTICLES IGF1R, IK, BMI1 DPP4 4366/4885NR1H2 1914/4885NR1H3 2587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback